Skip to contentS
Sanara MedTech Inc.
S
SMTISanara MedTech Inc. Q3 2014 · 10-Q
Revenue$679.12K$679.12K+43.7% vs Q3 2013 Net Income-$735.74K-$735.74KN/M vs Q3 2013 EPS Diluted-$0.01-$0.01N/M vs Q3 2013 Gross Profit$443,951+89.7% Operating Cash Flow
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Sanara MedTech Inc. · CIK 714256 · Engraved from SEC EDGAR
derived
Free Cash Flowderived-$284,031N/M Margins · derivedGross margin65.4%+15.9 pt vs Q3 2013
Net margin-108.3%+248.6 pt vs Q3 2013
ended Sep 30, 2014 · filed Nov 13, 2014 · 44 d after period end